Get access to our best features
Get access to our best features
Published 2 years ago

First US patient receives autologous stem cell therapy to treat dry AMD

Summary by Ground News
Dry AMD is a leading cause of vision loss among older Americans and currently has no treatment. The patient received the therapy as part of a clinical trial that is the first in the United States to use replacement tissues from patient-derived induced pluripotent stem (iPS) cells. This surgery is the culmination of 10 years of research and development at the National Eye Institute.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics